Abcentra
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Focused Orticumab Research for Treating Inflammation in Coronary Arteries (NCT06927739) | Abcentra | 2025-08-11 |
| A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors (NCT04776629) | Abcentra | 2021-06-30 |
Track Abcentra automatically
Every clearance here is in the API, with alerts when new ones post.